CytomX Therapeutics, Inc. (CTMX): Price and Financial Metrics

CTMX POWR Grades

• Value is the dimension where CTMX ranks best; there it ranks ahead of 69.61% of US stocks.
• CTMX's strongest trending metric is Stability; it's been moving down over the last 177 days.
• CTMX ranks lowest in Momentum; there it ranks in the 4th percentile.

CTMX Stock Summary

• Of note is the ratio of CYTOMX THERAPEUTICS INC's sales and general administrative expense to its total operating expenses; just 10.52% of US stocks have a lower such ratio.
• For CTMX, its debt to operating expenses ratio is greater than that reported by just 14.47% of US equities we're observing.
• With a year-over-year growth in debt of -20.83%, CYTOMX THERAPEUTICS INC's debt growth rate surpasses merely 14.18% of about US stocks.
• Stocks with similar financial metrics, market capitalization, and price volatility to CYTOMX THERAPEUTICS INC are SIMO, IKNA, PIRS, SYBX, and VTGN.
• Visit CTMX's SEC page to see the company's official filings. To visit the company's web site, go to www.cytomx.com.

CTMX Valuation Summary

• In comparison to the median Healthcare stock, CTMX's EV/EBIT ratio is 104.55% lower, now standing at -0.3.
• Over the past 91 months, CTMX's price/earnings ratio has gone up 11.7.

Below are key valuation metrics over time for CTMX.

CTMX Growth Metrics

The 3 year cash and equivalents growth rate now stands at -14.07%.
• Its 3 year revenue growth rate is now at -5.43%.
• The 3 year net cashflow from operations growth rate now stands at -30.48%.

CTMX's revenue has moved up $5,523,000 over the prior 15 months.

The table below shows CTMX's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	71.943	-140.586	-97.593
2022-06-30	72.615	-136.442	-96.881
2022-03-31	70.738	-130.404	-91.94
2021-12-31	69.573	-119.031	-83.609
2021-09-30	66.219	-105.266	-72.082
2021-06-30	66.42	-100.244	-64.208

CTMX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• CTMX has a Quality Grade of D, ranking ahead of 22.16% of graded US stocks.
• CTMX's asset turnover comes in at 0.169 -- ranking 210th of 682 Pharmaceutical Products stocks.
• JNJ, LEXX, and ORGS are the stocks whose asset turnover ratios are most correlated with CTMX.

The table below shows CTMX's key quality metrics over time.